Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: A marker for atherosclerosis?

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 955-961

  Ulutas, Kemal Turker ^a   Dokuyucu, Recep ^b   Sefil, Fatih ^b   Yengil, Erhan ^b   Sumbul, Ahmet Taner ^b   Rizaoglu, Hatice ^b   Ustun, Ihsan ^b   Yula, Erkan ^b   Sabuncu, Tevfik ^c   Gokce, Cumali ^b  

^a Kadirli State Hospital   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Diabetes duration; Glucose regulation; MPV

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE REGULATION SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; THROMBOCYTE VOLUME;

EID: 84900431845     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Beckman JA, Creager MA and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581.
2. Colwell JA and Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 2003; 26: 2181-2188.
3. Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gokce C, Kalkan A and Yazici C. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord 2009; 7: 427-434.
4. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999; 100: 1132-1133.
5. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J and Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-423.
6. Saglam H, Seyfeli E, Gul I, Duru M and Gokce C. Index of myocardial performance in patients with type 2 diabetes without hypertension and its relationship with clinical and echocardiographic parameters. J Diabetes 2009; 1: 50-56.
7. Vericel E, Januel C, Carreras M, Moulin P and Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 2004; 53: 1046-1051.
8. Chiha M, Njeim M and Chedrawy EG. Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens 2012; 2012: 697240.
9. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ and Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006; 368: 1651-1659.
10. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K and Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-1834.
11. van der Loo B and Martin JF. Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 1997; 10: 109-123.
12. Tufano A, Cimino E, Di Minno MN, Ierano P, Marrone E, Strazzullo A, Di Minno G and Cerbone AM. Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. Int J Vasc Med 2011; 2011: 250518.
13. Kaplan ZS and Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011; 2011: 51-61.
14. Hekimsoy Z, Payzin B, Ornek T and Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004; 18: 173-176.
15. Kakouros N, Rade JJ, Kourliouros A and Resar JR. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011; 2011: 742719.
16. Torun AN, Eren MA, Ulaş T, Demir M, Arslan I, Sabuncu T. Mean Platelet Volume in Various Degrees of Disturbed Carbohydrate Metabolism. Turkish Journal of Endocrinology and Metabolism 2012; 16: 6-9.
17. Vinik AI, Erbas T, Park TS, Nolan R and Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001; 24: 1476-1485.
18. Zuberi BF, Akhtar N and Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J 2008; 49: 114-116.
19. Andersson C, van Gaal L, Caterson ID, Weeke P, James WP, Coutinho W, Finer N, Sharma AM, Maggioni AP and Torp-Pedersen C. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia 2012; 55: 2348-2355.
20. Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, Koh YY, Chang KS and Hong SP. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2013; 24: 401-6.
21. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T and Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
22. Alberti KG and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36 Suppl 1: S67-74.
24. Boos CJ and Lip GY. Assessment of mean platelet volume in coronary artery disease - what does it mean? Thromb Res 2007; 120: 11-13.
25. Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HK and Lakshmaiah V. Mean platelet volume in Type 2 diabetes mellitus. J Lab Physicians 2012; 4: 5-9.
26. Shah AS, Dolan LM, Kimball TR, Gao Z, Khoury PR, Daniels SR and Urbina EM. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 3740-3745.
27. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N and Nakayama T. Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals. Cardiovasc Diabetol 2013; 12: 14.
28. Balasubramaniam K, Viswanathan GN, Marshall SM and Zaman AG. Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy. Cardiol Res Pract 2012; 2012: 909154.
29. Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, Lopes-Virella M, Reusch J, Ruderman N, Steiner G and Vlassara H. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 2002; 105: e138-143.
30. Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care 2009; 32: 525-527.
31. Yeboah J, Bertoni AG, Herrington DM, Post WS and Burke GL. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011; 58: 140-146.
32. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Jimenez-Quevedo P, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA and Macaya C. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 2005; 54: 2430-2435.
33. Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD and Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 2006; 59: 146-149.
34. Khode V, Sindhur J, Kanbur D, Ruikar K and Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res 2012; 3: 272-275.
35. Schneider DJ, Nordt TK and Sobel BE. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993; 42: 1-7.
36. Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K and Singh S. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 2011; 16: 86-89.
37. Bae SH, Lee J, Roh KH and Kim J. Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol 2003; 17: 140-144.
38. Sewell R, Ibbotson RM, Phillips R and Carson P. High mean platelet volume after myocardial infarction: is it due to consumption of small platelets? Br Med J (Clin Res Ed) 1984; 289: 1576-1578.
39. Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M and Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications 2009; 23: 89-94.